MedPath

Prebiotic Effect on Metabolites in Crohn's Disease

Not Applicable
Completed
Conditions
Crohn Disease
Interventions
Dietary Supplement: Oligofructose enriched inulin
Dietary Supplement: Maltodextrin
Registration Number
NCT01487759
Lead Sponsor
KU Leuven
Brief Summary

The purpose of this study is to investigate the influence of the prebiotic oligofructose enriched inulin on the metabolite pattern in Crohn's disease patients.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
67
Inclusion Criteria
  • crohn's disease
Exclusion Criteria
  • severe crohn's disease (harvey bradshaw index >12)
  • pregnancy
  • history of colectomy
  • use of antibiotics 4-wks before start of the study
  • use of sulfapyridine
  • use of commercially available prebiotics and probiotics

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
PrebioticOligofructose enriched inulin-
PlaceboMaltodextrin-
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

KULeuven

🇧🇪

Leuven, Belgium

© Copyright 2025. All Rights Reserved by MedPath